BODY-COMPOSITION AND ENERGY-EXPENDITURE IN ACROMEGALY

被引:105
作者
OSULLIVAN, AJ [1 ]
KELLY, JJ [1 ]
HOFFMAN, DM [1 ]
FREUND, J [1 ]
HO, KKY [1 ]
机构
[1] ST VINCENTS HOSP, GARVAN INST MED RES, DEPT NUCL MED, SYDNEY, NSW 2010, AUSTRALIA
关键词
D O I
10.1210/jc.78.2.381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate whether GH is a regulator of body composition and energy metabolism in adult life, we have compared body composition and resting energy expenditure (REE) in a cross-sectional study in 20 acromegalic and 20 normal subjects, pair-matched for sex, age, height, and weight. In a longitudinal study, 8 acromegalic patients were also studied before and after 12 weeks of treatment [n = 6 during octreotide (100 mu g, 3 times/day); n = 2 after pituitary surgery], and 7 patients were studied 12 weeks after withdrawal of octreotide. REE was measured by indirect calorimetry and fat mass and fat-free soft tissue mass (FFSTM) by dual energy x-ray absorptiometry. A subgroup of 12 matched pairs of subjects and 7 treated patients had measurement of extracellular water (ECW) by Na-24 dilution, which when subtracted from FFSTM provided an estimate of body cell mass (BCM). Fat mass was significantly reduced (25.4 +/- 2.2 vs. 29.7 +/- 2.7 kg; P = 0.007) and FFSTM increased (53.3 +/- 2.2 vs. 49.2 +/- 2.3 kg; P = 0.003) in acromegaly with ECW (25.6 +/- 1.6 us. 21.1 +/- 0.9 L; P = 0.0003), but not BCM, significantly elevated. Treatment of acromegaly increased fat mass and reduced FFSTM [change (Delta), -1.3 +/- 0.4 kg; P = 0.004]; the latter reflected a significant fall in ECW (Delta, -2.2 +/- 0.4 L; P = 0.002), but not BCM. The opposite effect on body composition occurred after treatment withdrawal. REE was increased in acromegaly (1682 +/- 49 us. 1540 +/- 45 Cal/24 h; P = 0.02) and significantly related to insulinlike growth factor-I (P = 0.02). REE was significantly reduced (Delta, -154 +/- 17 Cal/24 h; P = 0.0001) with treatment and increased after treatment withdrawal (P = 0.003). In acromegaly, there is a reversible 1) reduction in fat mass; 2) increase in FFSTM, accounted for by an increase in ECW, but not BCM; and 3) increase in REE, which is dependent on disease activity. We conclude from these observations in acromegaly that GH is a regulator of energy metabolism and body composition.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 40 条
[11]   ACUTE METABOLIC EFFECTS OF HUMAN GROWTH-HORMONE [J].
FINEBERG, SE ;
MERIMEE, TJ .
DIABETES, 1974, 23 (06) :499-504
[12]   PERIPHERAL GLUCOSE-METABOLISM IN ACROMEGALY [J].
FOSS, MC ;
SAAD, MJA ;
PACCOLA, GMGF ;
PAULA, FJA ;
PICCINATO, CE ;
MOREIRA, AC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05) :1048-1053
[13]   CALCULATION OF SUBSTRATE OXIDATION RATES INVIVO FROM GASEOUS EXCHANGE [J].
FRAYN, KN .
JOURNAL OF APPLIED PHYSIOLOGY, 1983, 55 (02) :628-634
[14]   CATABOLIC EFFECTS OF THYROID-HORMONE EXCESS - THE CONTRIBUTION OF ADRENERGIC ACTIVITY TO HYPERMETABOLISM AND PROTEIN BREAKDOWN [J].
GELFAND, RA ;
HUTCHINSONWILLIAMS, KA ;
BONDE, AA ;
CASTELLINO, P ;
SHERWIN, RS .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (06) :562-569
[15]   VALIDATION OF BODY-COMPOSITION BY DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA) [J].
HAARBO, J ;
GOTFREDSEN, A ;
HASSAGER, C ;
CHRISTIANSEN, C .
CLINICAL PHYSIOLOGY, 1991, 11 (04) :331-341
[16]   EFFECTS OF HUMAN GROWTH HORMONE IN MAN [J].
HENNEMAN, PH ;
FORBES, AP ;
MOLDAWER, M ;
DEMPSEY, EF ;
CARROLL, EL .
JOURNAL OF CLINICAL INVESTIGATION, 1960, 39 (08) :1223-1238
[17]   DUAL-PHOTON ABSORPTIOMETRY - COMPARISON OF BONE-MINERAL AND SOFT-TISSUE MASS MEASUREMENTS INVIVO WITH ESTABLISHED METHODS [J].
HEYMSFIELD, SB ;
WANG, J ;
HESHKA, S ;
KEHAYIAS, JJ ;
PIERSON, RN .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (06) :1283-1289
[18]   THE ANTINATRIURETIC ACTION OF BIOSYNTHETIC HUMAN GROWTH-HORMONE IN MAN INVOLVES ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM [J].
HO, KY ;
WEISSBERGER, AJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (02) :133-137
[19]   THERAPEUTIC EFFICACY OF THE SOMATOSTATIN ANALOG SMS-201-995 (OCTREOTIDE) IN ACROMEGALY - EFFECTS OF DOSE AND FREQUENCY AND LONG-TERM SAFETY [J].
HO, KY ;
WEISSBERGER, AJ ;
MARBACH, P ;
LAZARUS, L .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (03) :173-181
[20]   HUMAN GROWTH-HORMONE PREVENTS THE PROTEIN CATABOLIC SIDE-EFFECTS OF PREDNISONE IN HUMANS [J].
HORBER, FF ;
HAYMOND, MW .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :265-272